- Corporate Officers - P
- Pace Gary W
Insider Trading History of Pace Gary W
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Pace Gary W since 2015.
This trader's CIK number is 1184778.
At the time of last reporting, Pace Gary W was the Officer of Cardiff Oncology, Inc.. (stock ticker symbol CRDF).
Also see all insider trading activities at Cardiff Oncology, Inc..
Note that in the past
PACE GARY W also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Cardiff Oncology, Inc. (CRDF) by Pace Gary W
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | CRDF | 290,000 | $710,500 | 0 | $0 | 0 | $0 |
| 2024 | CRDF | 361,615 | $940,199 | 0 | $0 | 0 | $0 |
| 2023 | CRDF | 30,000 | $41,100 | 0 | $0 | 0 | $0 |
| 2022 | CRDF | 150,000 | $256,500 | 0 | $0 | 0 | $0 |
| 2021 | CRDF | 44,500 | $350,477 | 0 | $0 | 0 | $0 |
| 2020 | CRDF | 450,311 | $614,534 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Pacira Biosciences, Inc. (PCRX) by Pace Gary W
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | PCRX | 0 | $0 | 119,323 | $3,656,226 | 0 | $0 |
| 2023 | PCRX | 0 | $0 | 5,015 | $209,526 | 7,000 | $209,300 |
| 2022 | PCRX | 0 | $0 | 30,000 | $2,006,150 | 37,000 | $406,269 |
| 2020 | PCRX | 0 | $0 | 0 | $0 | 91,736 | $1,269,124 |
| 2018 | PCRX | 8,500 | $412,970 | 0 | $0 | 0 | $0 |
| 2015 | PCRX | 1,000 | $93,830 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Resmed Inc (RMD) by Pace Gary W
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | RMD | 0 | $0 | 28,403 | $2,765,600 | 28,403 | $783,354 |
| 2017 | RMD | 0 | $0 | 24,390 | $1,853,640 | 24,390 | $821,943 |
| 2016 | RMD | 0 | $0 | 72,000 | $4,677,336 | 72,000 | $1,778,940 |
| 2015 | RMD | 0 | $0 | 48,000 | $3,204,816 | 48,000 | $791,904 |
Insider trading activities at 3 companies by Pace Gary W:
1. Cardiff Oncology, Inc. (CRDF)
2. Pacira Biosciences, Inc. (PCRX)
3. Resmed Inc (RMD)
Table 1. Insider trading of Cardiff Oncology, Inc. (CRDF) by Pace Gary W
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-07-30 | CRDF | Buy | 290,000 | 2.45 | 710,500 |
| 2024-12-11 | CRDF | Buy | 361,615 | 2.60 | 940,199 |
| 2023-12-19 | CRDF | Buy | 30,000 | 1.37 | 41,100 |
| 2022-09-15 | CRDF | Buy | 150,000 | 1.71 | 256,500 |
| 2021-09-21 | CRDF | Buy | 30,000 | 6.75 | 202,500 |
| 2021-03-23 | CRDF | Buy | 10,000 | 10.24 | 102,400 |
| 2021-03-18 | CRDF | Buy | 3,000 | 10.56 | 31,680 |
| 2021-03-04 | CRDF | Buy | 1,500 | 9.27 | 13,897 |
| 2020-09-16 | CRDF | Buy | 2,550 | 5.70 | 14,535 |
| 2020-05-11 | CRDF | Buy | 447,761 | 1.34 | 599,999 |
Table 2. Insider trading of Pacira Biosciences, Inc. (PCRX) by Pace Gary W
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-03-08 | PCRX | Sale | 90,000 | 30.60 | 2,754,000 |
| 2024-03-06 | PCRX | Sale | 1,066 | 29.67 | 31,628 |
| 2024-03-07 | PCRX | Sale | 28,257 | 30.81 | 870,598 |
| 2023-05-11 | PCRX | Sale | 5,015 | 41.78 | 209,526 |
| 2023-05-11 | PCRX | Option Ex | 7,000 | 29.90 | 209,300 |
| 2022-03-03 | PCRX | Option Ex | 7,000 | 10.81 | 75,670 |
| 2022-02-28 | PCRX | Option Ex | 28,641 | 11.02 | 315,623 |
| 2022-03-01 | PCRX | Option Ex | 1,359 | 11.02 | 14,976 |
| 2022-02-28 | PCRX | Sale | 28,641 | 66.83 | 1,914,078 |
| 2022-03-01 | PCRX | Sale | 1,359 | 67.75 | 92,072 |
| 2020-09-25 | PCRX | Option Ex | 70,000 | 16.67 | 1,166,900 |
| 2020-03-12 | PCRX | Option Ex | 21,736 | 4.70 | 102,224 |
| 2018-11-19 | PCRX | Buy | 4,500 | 46.18 | 207,810 |
| 2018-11-07 | PCRX | Buy | 4,000 | 51.29 | 205,160 |
| 2015-03-13 | PCRX | Buy | 1,000 | 93.83 | 93,830 |
Table 3. Insider trading of Resmed Inc (RMD) by Pace Gary W
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-05-08 | RMD | Option Ex | 28,403 | 27.58 | 783,354 |
| 2018-05-08 | RMD | Sale | 28,403 | 97.37 | 2,765,600 |
| 2017-06-15 | RMD | Sale | 22,660 | 76.00 | 1,722,160 |
| 2017-06-14 | RMD | Sale | 1,730 | 76.00 | 131,480 |
| 2017-06-15 | RMD | Option Ex | 22,660 | 33.70 | 763,642 |
| 2017-06-14 | RMD | Option Ex | 1,730 | 33.70 | 58,301 |
| 2016-08-19 | RMD | Option Ex | 36,000 | 25.54 | 919,440 |
| 2016-08-19 | RMD | Sale | 36,000 | 69.93 | 2,517,336 |
| 2016-03-11 | RMD | Option Ex | 36,000 | 23.88 | 859,500 |
| 2016-03-11 | RMD | Sale | 36,000 | 60.00 | 2,160,000 |
| 2015-01-26 | RMD | Option Ex | 48,000 | 16.50 | 791,904 |
| 2015-01-26 | RMD | Sale | 48,000 | 66.77 | 3,204,816 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Pace Gary W
(Officer of Cardiff Oncology, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.